TY - JOUR AB - Angiosarcoma (AS) is a rare and aggressive tumor with high rates of local recurrence and distant metastasis. Stewart‑Treves syndrome (STS) is defined as AS arising in the setting of chronic lymphedema, and is extremely uncommon in the lower abdominal wall. Eribulin mesylate (eribulin) is a non‑taxane microtubule inhibitor that has been approved in Japan for treating soft tissue sarcoma. The current study reports the case of a 76 year‑old woman with STS in the lower abdominal wall who exhibited an excellent response to eribulin. Having undergone surgery and postoperative radiation therapy (RT) for cervical cancer 12 years earlier, the patient presented with a mass in her left lower abdominal wall, where chronic lymphedema had developed. Contrast‑enhanced computed tomography revealed multiple enhancing nodules in the left lower abdominal wall and edema of the subcutaneous tissues in the whole lower abdomen. A histologic analysis of the specimens revealed AS, and she was diagnosed as STS. A total of 3 cycles of combination chemotherapy with gemcitabine and docetaxel were administered, but the patient discontinued treatment owing to severe adverse events. RT was performed for the tumor, but multiple reddish nodules appeared in the whole lower abdominal wall 3 months later. At this point, eribulin administration was offered. After 4 cycles of treatment, there was a clear reduction in the size of the nodules. All lesions were stable, no new lesions had developed, and the side effects of treatment were minor over the course of 1 year. The results reveal that eribulin may serve as a potential therapeutic option for the treatment of STS. AD - Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka 541‑8567, Japan Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka 541‑8567, Japan AU - Imura,Yoshinori AU - Nagata,Shigenori AU - Wakamatsu,Toru AU - Tanaka,Takaaki AU - Tamiya,Hironari AU - Naka,Norifumi AU - Takenaka,Satoshi DA - 2020/11/01 DO - 10.3892/mco.2020.2119 IS - 5 JO - Mol Clin Oncol KW - angiosarcoma Stewart‑Treves syndrome chronic lymphedema eribulin cervical cancer PY - 2020 SN - 2049-9450 2049-9469 SP - 49 ST - A case of Stewart‑Treves syndrome occurring in the abdominal wall successfully treated with eribulin: A case report T2 - Molecular and Clinical Oncology TI - A case of Stewart‑Treves syndrome occurring in the abdominal wall successfully treated with eribulin: A case report UR - https://doi.org/10.3892/mco.2020.2119 VL - 13 ER -